47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
68.20.Z - Rental and management of own or leased real estate
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,5 | 0,5 | -4,5 |
Gross profit (loss) | 0,5 | 0,6 | 0,5 | -25,2 |
EBITDA | 0,6 | 0,7 | 0,5 | -22,8 |
Short time liabilities | 0,3 | 0,2 | 0,2 | -5 |
Other operating costs | 0 | 0 | 0 | -6,6 |
Equity capital | 1 | 1,3 | 1,4 | 10,2 |
Operating profit (EBIT) | 0,5 | 0,6 | 0,5 | -25 |
Assets | 1,5 | 1,5 | 1,6 | 6,1 |
Net profit (loss) | 0,5 | 0,6 | 0,5 | -25,2 |
Cash | 0 | 0,1 | 0,1 | -6,4 |
Net income from sale | 7,7 | 7,9 | 8,5 | 7,3 |
Liabilities and provisions for liabilities | 0,5 | 0,2 | 0,2 | -19,7 |
Working assets | 1,1 | 1,2 | 1,4 | 12,6 |
Other income costs | 0,1 | 0,2 | 0 | -79,4 |
Depreciation | 0,1 | 0,1 | 0,1 | -1,8 |
% | % | % | p.p. | |
Profitability of capital | 52,2 | 45,9 | 31,2 | -14,7 |
Equity capital to total assets | 66,1 | 86,2 | 89,6 | 3,4 |
Gross profit margin | 6,8 | 7,7 | 5,3 | -2,4 |
EBITDA Margin | 7,8 | 8,5 | 6,1 | -2,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 14 | 8 | 7 | -1 |
Current financial liquidity indicator | 3.9172286987304688 | 7.1168341636657715 | 8.434739112854004 | 1,3 |
Net dept to EBITDA | 0.4906444847583771 | -0.06803013384342194 | -0.1533534973859787 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane